Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* HealthCor Management, L.P.	2. Issuer Name and Ticker or Trading Symbol CareView Communications Inc [ CRVW.OB ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 55 HUDSON YARDS, 28TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 12/31/2019
(Street) NEW YORK, NY 10001 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Senior Secured Convertible Note due 2024 (PIK Interest) ⁽¹⁾	$0.40	12/31/2019		A		$115540		⁽²⁾	1/15/2024	Common Stock	288851	$0	$4737149	I	By HCP Fund ⁽³⁾
Senior Secured Convertible Note due 2024 (PIK Interest) ⁽¹⁾	$0.40	12/31/2019		A		$132507		⁽²⁾	1/15/2024	Common Stock	331267	$0	$5432772	I	By Hybrid Fund ⁽⁴⁾
Senior Secured Convertible Note due 2029 (PIK Interest) ⁽¹⁾	$0.03	12/31/2019		A		$1637		⁽²⁾	5/14/2029	Common Stock	54559	$0	$54013	I	By Jeffrey Lightcap

Explanation of Responses:
(1)	On December 31, 2019, the 2014 Notes held by HCP Fund and Hybrid Fund and the 2019 Note held by Mr. Lightcap accrued interest which is payable in kind ("PIK Interest") in the form of additional principal. Excludes PIK interest on notes issued to certain reporting persons and other investors on February 17, 2015, February 23, 2018, and July 13, 2018, reporting of which is exempt pursuant to Rule 16a-9.
(2)	Immediately exercisable.
(3)	HealthCor Partners Fund, L.P. ("HCP Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Partners L.P. serves as its general partner and HealthCor Partners GP, LLC ("HCPGP") serves as the general partner of HealthCor Partners L.P. HealthCor Partners Management, L.P. serves as the investment manager to HCP Fund and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner to HealthCor Partners Management, L.P. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities. Mr. Lightcap was appointed a director of the issuer in connection with the initial investment.
(4)	HealthCor Hybrid Offshore Master Fund, L.P. ("Hybrid Fund") is a private investment partnership which is the direct beneficial owner of the securities reported herein. HealthCor Hybrid Offshore GP, LLC ("Offshore GP") serves as its general partner and HealthCor Group, LLC ("Group") serves as the general partner of Offshore GP. HealthCor Management, L.P. serves as the investment manager to Hybrid Fund and HealthCor Associates, LLC ("Associates") serves as the general partner to HealthCor Management, L.P. Arthur Cohen and Joseph Healey are managing members of Associates and Group. Each reporting person disclaims beneficial ownership of any securities that exceed their pecuniary interest in the securities held by these entities.

Remarks:
HealthCor Management, L.P. is the designated filer on behalf of the reporting persons listed on Exhibit 99.1, attached hereto. Due to the number of reporting persons, this is one of two Form 4s filed relating to the same securities.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
HealthCor Management, L.P. 55 HUDSON YARDS, 28TH FLOOR NEW YORK, NY 10001	X	X
HealthCor Associates, LLC 55 HUDSON YARDS, 28TH FLOOR NEW YORK, NY 10001	X	X
HealthCor Hybrid Offshore Master Fund, L.P. 55 HUDSON YARDS, 28TH FLOOR NEW YORK, NY 10001	X	X
HealthCor Hybrid Offshore GP, LLC 55 HUDSON YARDS, 28TH FLOOR NEW YORK, NY 10001	X	X
HealthCor Group, LLC 55 HUDSON YARDS, 28TH FLOOR NEW YORK, NY 10001	X	X
HealthCor Partners Management LP 1325 AVENUE OF AMERICAS, 28TH FLOOR NEW YORK, NY 10019	X	X
HealthCor Partners Management GP, LLC 1325 AVENUE OF AMERICAS, 28TH FLOOR NEW YORK, NY 10019	X	X
HealthCor Partners Fund LP 1325 AVENUE OF AMERICAS, 28TH FLOOR NEW YORK, NY 10019	X	X
HealthCor Partners LP 1325 AVENUE OF AMERICAS, 28TH FLOOR NEW YORK, NY 10019	X	X

Signatures
HealthCor Management, L.P., By: HealthCor Associates, LLC, its general partner, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date
HealthCor Hybrid Offshore GP, LLC for itself and as general partner on behalf of HealthCor Hybrid Offshore Master Fund, L.P., By: HealthCor Group, LLC, its general partner, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date
HealthCor Associates, LLC, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date
HealthCor Group, LLC, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date
HealthCor Partners Management, L.P., By: HealthCor Partners Management GP, LLC, its general partner, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date
HealthCor Partners Management GP, LLC, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date
HealthCor Partners L.P., for itself, and as general partner on behalf of Healthcor Partners Fund, L.P., By: HealthCor Partners GP, LLC, its general partner, By: /s/ Anabelle P. Gray, General Counsel		1/2/2020
^**Signature of Reporting Person		Date